PHILADELPHIA, Jan. 03, 2023 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 41

^st

Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 9, 2023 at 2:15 p.m. PT.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at

https://ir.amicusrx.com/events-and-presentations

.

About Amicus Therapeutics



Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at


www.amicusrx.com


, and follow on


Twitter


and


LinkedIn


.

CONTACT:

Investors:


Amicus Therapeutics

Andrew Faughnan

Executive Director, Investor Relations


[email protected]


(609) 662-3809

Media:


Amicus Therapeutics

Diana Moore

Head of Global Communications


[email protected]


(609) 662-5079

FOLD–G